Infusionz sells CBD candies, gummies, tinctures and pet products that FDA calls adulterated and illegally marketed.
What happened
FDA reviewed cbdinfusionz.com in October 2022 and the company’s Facebook and Instagram pages, which direct consumers to the website to buy products represented as containing CBD. FDA said it analyzed samples of the gummy, gum and lollipop products and confirmed they contain CBD. FDA determined the CBD gummies, fruit snacks, gum, candy, oil/tinctures and lollipops are adulterated foods containing an unsafe food additive and are prohibited in interstate commerce, and it also raised concerns about CBD dog treats and tincture marketed for animal conditions.
What FDA found
The CBD gummies, fruit snacks, gum, candy, oil/tinctures, and lollipops are foods with added CBD, which FDA treats as an unsafe food additive because CBD is not approved for use in conventional food.
FD&C Act § 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i); § 409(a), 21 U.S.C. 348(a)Selling those CBD foods across state lines is prohibited because CBD is the active ingredient in an approved drug and substantial clinical investigations of CBD have been made public.
FD&C Act § 301(ll), 21 U.S.C. 331(ll)Selling adulterated food across state lines is prohibited.
FD&C Act § 301(a), 21 U.S.C. 331(a)The CBD dog treats and hemp CBD tincture are marketed for animal conditions such as separation anxiety, noise aversion, and seizures, and CBD is not an approved food additive or GRAS for animal food.
21 CFR 570.30
What FDA wants
FDA asks Infusionz to notify it in writing within 15 working days of the steps taken to address the violations, including how it will prevent recurrence and copies of related documents. If corrective actions cannot be completed in that time, the company must state why and give a timeframe.
Who should pay attention
- retailers and online marketplaces selling CBD foods
- brands using CBD in conventional foods or pet products
- contract manufacturers of CBD gummies, candy, and tinctures
This is a summary. Read the original letter on fda.gov.